If you are interested in ‘Ingestible devices for advanced drug delivery’ please see our #ADDR Special Issue (edited by Maya Thanou and myself) with some fantastic contributions sciencedirect.com/journal/advanc…

The next speaker School of Cancer & Pharmaceutical Sciences #MedicinesDevelopment seminar is Kofi Asare-Addo Asare-Addo Research Group 💊 Looking forward to your talk!

For a birthday present my daughter received this (cute) Cocomelon doctor set, which included a syringe. Working on non-invasive drug delivery, I’m not sure I fully approve 🤔

ADDR 50 days' free access: [Preface] "Of devices and drugs – ingestible bots for diagnosis and therapy" By Driton Vllasaliu & Maya Thanou School of Cancer & Pharmaceutical Sciences Maya Thanou Driton Vllasaliu #ingestibledevice #diagnosis authors.elsevier.com/a/1ef4d,3sXTer…

Great to see this achievement for King’s in REF 2021: Allied health professions, dentistry, nursing and pharmacy. timeshighereducation.com/news/ref-2021-… via Times Higher Education

Excellent talk! Thanks for coming!! Driton Vllasaliu Khuloud Al-Jamal FRPharmS FRSC School of Cancer & Pharmaceutical Sciences King's College London Pharmacy 🌈

linkedin.com/posts/activity…

linkedin.com/posts/activity…

We are pleased to announce that Driton Vllasaliu (Dr Driton Vllasaliu) has been awarded almost €1 million by EuropeAid to help strengthen research and innovation in Environment and Medical Research in Kosovo 🥳 1/4

Congrats Driton Vllasaliu !! 🥳🥳

Dr Driton Vllasaliu Driton Vllasaliu at King's College London is undertaking a pilot study in developing an improved organoid model of the human intestine to study gastrointestinal disease. Read more here - bit.ly/3ZwNxpU #BSW2023

Thoroughly enjoyed the NanoKos project kick-off meeting and workshop today at the University of Prishtina. Moved by the amazingly warm welcome by students & staff of the university and support by the Kosovo government University of Prishtina

Our latest #publication in Journal of Nanobiotechnology investigates milk #extracellularvesicles for intestinal delivery of #RNA therapies using ‘flipped’ and monolayer human intestinal #organoids and #IBD as a target disease rdcu.be/dqeyK

We’re investing £100m in six new Engineering Biology Mission Hubs and 22 Mission Awards projects to address challenges in areas like vaccine development, food production and plastic pollution. More: orlo.uk/nPSwE Biotechnology and Biological Sciences Research Engineering and Physical Sciences Research Council Department for Science, Innovation and Technology

We are delighted to have been selected for an #EngineeringBiology Mission Award for a project that will engineer milk #ExtracellularVesicles into oral nucleic acid therapies. Look forward to working with Maya Thanou, Alan Goddard, Snow Stolnik and Cameron Alexander

And congrats to the King’s lab that received an #EngineeringBiology Mission Award worth £1.4 million by UK Research and Innovation for a project that will engineer tiny milk particles into accessible oral therapies! 🎉 Driton Vllasaliu Aston University Uni of Nottingham #WeAreUoN kcl.ac.uk/news/kings-rec…

I’m delighted to see our research on oral #RNA delivery via #extracellularvesicles being featured on Freethink freethink.com/health/rna-the…

Well done to Lina Wu The Raimi-Abraham Group for her hard work and congratulations on her first paper from the PhD!! 🥳 Thanks also to Qi Cui and Dr Driton Vllasaliu Driton Vllasaliu for their contribution to the work! 🙌 School of Cancer & Pharmaceutical Sciences King's Faculty of Life Sciences & Medicine

Very happy to see our work out comparing nanoparticle endocytosis pathways in different epithelial culture models. Led by Prof Snow Stolink, Driton Vllasaliu Mol Pharm UoNPharmacy Find in Molecular Pharmaceutics: pubs.acs.org/doi/10.1021/ac…

Father’s Day gift from wife. Efficacy TBC (dubious).